Abstract
Microcephaly is a clinical condition defined as a reduction in head circumference and brain volume. The abnormal brain size may result from pathological neural stem cell (NSC) proliferation, survival, differentiation and migration during the development of the cerebral cortex. This process is controlled by many factors, including microRNAs that normally silence target genes at the posttranscriptional level. In this review, we will discuss the roles of microRNAs involved in different stages of the cortical development to shed light on the pathogenesis of microcephaly. Understanding the molecular mechanisms of microRNA-mediated cortical development may help develop a means of microRNA-based diagnosis and treatment for microcephaly in humans.
Keywords: Cerebral cortex, microcephaly, microRNA, neural stem cell, neural progenitor, neurogenesis.
Graphical Abstract
Current Molecular Pharmacology
Title:microRNAs and Molecular Pathogenesis of Microcephaly
Volume: 9
Author(s): Xuqing Liu and Tao Sun
Affiliation:
Keywords: Cerebral cortex, microcephaly, microRNA, neural stem cell, neural progenitor, neurogenesis.
Abstract: Microcephaly is a clinical condition defined as a reduction in head circumference and brain volume. The abnormal brain size may result from pathological neural stem cell (NSC) proliferation, survival, differentiation and migration during the development of the cerebral cortex. This process is controlled by many factors, including microRNAs that normally silence target genes at the posttranscriptional level. In this review, we will discuss the roles of microRNAs involved in different stages of the cortical development to shed light on the pathogenesis of microcephaly. Understanding the molecular mechanisms of microRNA-mediated cortical development may help develop a means of microRNA-based diagnosis and treatment for microcephaly in humans.
Export Options
About this article
Cite this article as:
Liu Xuqing and Sun Tao, microRNAs and Molecular Pathogenesis of Microcephaly, Current Molecular Pharmacology 2016; 9 (4) . https://dx.doi.org/10.2174/1874467208666150928153949
DOI https://dx.doi.org/10.2174/1874467208666150928153949 |
Print ISSN 1874-4672 |
Publisher Name Bentham Science Publisher |
Online ISSN 1874-4702 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Virulence Factors of Helicobacter pylori: Practical Biomarkers
Recent Patents on Biomarkers GSTP1 Polymorphisms and their Association with Glutathione Transferase and Peroxidase Activities in Patients with Motor Neuron Disease
CNS & Neurological Disorders - Drug Targets Tau Positive Neurons Show Marked Mitochondrial Loss and Nuclear Degradation in Alzheimer's Disease
Current Alzheimer Research Neuroprotective effects of the securinine-analogues: identification of Allomargaritarine as a lead compound
CNS & Neurological Disorders - Drug Targets Development of RET Kinase Inhibitors for Targeted Cancer Therapy
Current Medicinal Chemistry ATP-Binding Cassette Transporters in Inflammatory Brain Disease
Current Pharmaceutical Design The Effects of Newer Beta-Adrenoceptor Antagonists on Vascular Function in Cardiovascular Disease
Current Vascular Pharmacology Traditional Fruits of Kerala: Bioactive Compounds and their Curative Potential in Chronic Diseases
Current Nutrition & Food Science Unique Coronary Artery Disease Differences in Women as Related to Revascularization
Current Medicinal Chemistry Patent Selections
Recent Patents on CNS Drug Discovery (Discontinued) Clinically Relevant Drug Interactions with Anti-Alzheimer's Drugs
CNS & Neurological Disorders - Drug Targets Evaluation of Salivary Vitamin C and Catalase in HIV Positive and Healthy HIV Negative Control Group
Infectious Disorders - Drug Targets Nose-to-brain Delivery of Natural Compounds for the Treatment of Central Nervous System Disorders
Current Pharmaceutical Design Editorial [Hot Topic: Innate Immunity and Autoimmune Disease (Guest Editors: F. Susan Wong and Li Wen)]
Current Molecular Medicine Risk Analysis of Lurasidone in Patients with Schizophrenia and Bipolar Depression
CNS & Neurological Disorders - Drug Targets The Spatial QRS-T Angle: Implications in Clinical Practice
Current Cardiology Reviews Soy Isoflavone Alleviates Aβ1-42-Induced Impairment of Learning and Memory Ability Through the Regulation of RAGE/LRP-1 in Neuronal and Vascular Tissue
Current Neurovascular Research Immune Regulation by the Posttranslational Modification O-GlcNAc
Current Signal Transduction Therapy The Yin and Yang of BK Channels in Epilepsy
CNS & Neurological Disorders - Drug Targets Diversity-Oriented Synthetic Approaches for Furoindoline: A Review
Current Organic Synthesis